As per MRFR analysis, the US Sleeping Bruxism Treatment Market Size was estimated at 128.77 (USD Million) in 2023. The US Sleeping Bruxism Treatment Market Industry is expected to grow from 138.65(USD Million) in 2024 to 257.62 (USD Million) by 2035. The US Sleeping Bruxism Treatment Market CAGR (growth rate) is expected to be around 5.794% during the forecast period (2025 - 2035).
The US Sleeping Bruxism Treatment Market is witnessing several noteworthy trends driven primarily by an increase in awareness about oral health and sleep disorders. Growing reports of bruxism among the adult population, influenced by stress and anxiety levels, have generated significant attention towards effective treatment solutions. As the American Dental Association notes, the prevalence of sleep disorders is rising, prompting healthcare professionals to focus on bruxism as a significant concern.
This heightened awareness is leading to more patients seeking diagnosis and treatment options. Another key driver in this market is the advancement in dental technology and the growing adoption of custom-made dental appliances, like nightguards, which are becoming increasingly popular in managing bruxism.These custom solutions offer improved comfort and effectiveness, catering to the specific needs of patients. Moreover, the integration of telehealth services is gaining traction, allowing patients easy access to consultations and follow-ups from the comfort of their homes, thereby removing barriers to seeking treatment.
Additionally, there are emerging opportunities in holistic and alternative therapies that are starting to gain attention in the US market. Patients are looking for combined treatment approaches that address both the physiological and psychological aspects of bruxism. This trend opens doors for professionals to offer comprehensive treatment plans that may include stress management techniques, cognitive behavioral therapy, and lifestyle changes.
Furthermore, as research continues to evolve, the emphasis on preventive care is strengthening the overall market. Educational initiatives aimed at informing the public on the impacts of bruxism and the importance of timely intervention are becoming more prevalent. As these trends unfold, it is clear that the US Sleeping Bruxism Treatment Market is adapting to meet the growing needs of the population while providing effective solutions for bruxism.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
In the United States, there has been a significant rise in awareness regarding sleep disorders, including sleeping bruxism. The National Sleep Foundation has reported that approximately 50-70 million adults in the US suffer from some form of sleep disorder, which correlates with the growing recognition of conditions like bruxism. This awareness drives the demand for effective treatments.
Moreover, initiatives by organizations such as the American Academy of Sleep Medicine (AASM) are enhancing education about sleep health, thereby promoting the growth of the US Sleeping Bruxism Treatment Market Industry.This increasing focus on sleep health is expected to create a substantial market opportunity, pushing forward treatment options for affected individuals.
The US Sleeping Bruxism Treatment Market Industry is being bolstered by advancements in technology, particularly in the development of dental devices and therapy options. Innovations such as custom-fit mouthguards and biofeedback therapy have shown promising results in managing bruxism. According to the American Dental Association, emerging technologies in dental treatments are improving patient outcomes by enhancing comfort and efficacy.
For instance, around 30% of users report significant improvement in their symptoms with the latest mouthguard designs.This technological evolution is a driving force for the market as patients increasingly seek effective and comfortable treatment options.
The increase in stress and anxiety levels in the US population is another significant driver for the US Sleeping Bruxism Treatment Market. The American Psychological Association reported that over 70% of adults experience significant stress, leading to conditions such as bruxism. Stress management programs and educational campaigns being initiated by health organizations reflect an urgent need for effective treatment solutions for stress-induced bruxism.
As more people recognize the link between mental health and physical conditions, there is a growing demand for treatments that address the root causes of bruxism, ultimately expanding the market for these solutions.
The US Sleeping Bruxism Treatment Market showcases a comprehensive landscape, particularly evident in its diverse types focusing on Primary and Secondary Bruxism. Primary Bruxism, often categorized as sleep-related, typically occurs without an underlying medical condition, driven instead by factors like stress, anxiety, and sleep disorders. This type is significant within the market as it aligns with the rising awareness of mental health issues among the population; hence, creating a growing demand for effective treatment solutions.
Conversely, Secondary Bruxism arises as a result of other medical conditions or the intake of certain medications, implying that treatment strategies may involve a multifaceted approach.The understanding and identification of these types are crucial for healthcare professionals as they tailor interventions based on individual patient needs. A trend towards personalized healthcare and holistic approaches in therapy further emphasizes the importance of distinguishing between these two types.
As a significant portion of the population in the US grapples with sleep-related disorders, the potential market for effective treatments remains substantial. The ongoing integration of digital health solutions and innovative technologies also plays a pivotal role in shaping treatment modalities, catering to both primary and secondary forms of bruxism.These advancements not only enhance treatment efficacy but also improve patient compliance, reflecting the broader trends in healthcare that prioritize convenience and accessibility.
Furthermore, the emphasis on dental and oral health care is transforming how bruxism is recognized and managed within the healthcare continuum, impacting both public health initiatives and private sector investments in treatment options. The substantial focus on patient education as a key driver in managing bruxism effectively legitimizes its impact on overall oral health outcomes.This demographic engagement forms an integral part of market growth dynamics as stakeholders work collaboratively to innovate and optimize treatment frameworks tailored to mitigate the ramifications of bruxism effectively.
Thus, with a projected growth trajectory and evolving therapeutic solutions, the segmentation of the US Sleeping Bruxism Treatment Market around Type not only highlights critical areas for future exploration but underscores the complexity of factors influencing patient care.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Sleeping Bruxism Treatment Market focuses on various Treatment options aimed at alleviating the issues associated with bruxism. This segment notably includes Dental Approaches, which utilize devices such as mouthguards and splints that are designed to prevent teeth grinding and jaw clenching. These dental interventions are widely sought after due to their non-invasive nature and immediate effect on protecting dental health.
Medication also plays a crucial role in the Treatment segment, where pharmacological solutions are employed to manage muscle tension and reduce stress-related bruxism episodes.The combination of these Treatment methodologies is critical due to the rising awareness of dental health and the prevalence of stress-related disorders in the US population. Further market dynamics indicate an increasing inclination towards holistic approaches to treatment, with consumers actively seeking options that not only address symptoms but also promote overall well-being.
The rising incidence of bruxism-related disorders highlights the importance of effective treatment solutions to mitigate their impact on quality of life, underscoring the growing demand within this segment of the market.
The US Sleeping Bruxism Treatment Market has seen an evolving landscape focused on various causes of the condition. Obstructive Sleep Apnea, recognized as a prominent contributor to bruxism, affects millions in the US, leading to disruptions in sleep patterns and increased stress during rest periods. Gastroesophageal Reflux Disease emerges as another significant risk factor, often causing discomfort that can trigger teeth grinding as a coping mechanism.
Additionally, malocclusion, which refers to misalignment of teeth, has been noted for its correlation with bruxism, as improper bites can lead to increased dental stress and grinding.Sleep paralysis, although less common, is also associated with the condition, highlighting the intricate relationship between various sleep disorders and teeth grinding behavior.
Together, these factors underscore the importance of understanding the root causes of bruxism for effective treatment and management strategies. A well-rounded approach addressing these causes could present opportunities in the market for innovative treatment solutions while emphasizing the need for comprehensive patient education. Insights into the US Sleeping Bruxism Treatment Market segmentation illustrate a growing recognition of these interrelated factors, contributing to market growth and patient awareness.
The US Sleeping Bruxism Treatment Market is significantly shaped by the Patient Type segment, which comprises primarily of Pediatric and Adult categories. This segmentation is crucial as it addresses the differing treatment needs and prevalence rates of bruxism across age groups. Pediatric cases often arise due to factors such as stress or dental misalignment, necessitating age-specific therapeutic approaches, while Adult cases frequently correlate with stress, anxiety, and lifestyle choices.
The effective management of bruxism in both groups not only minimizes dental wear and associated health issues but also enhances overall quality of life.As awareness of sleep disorders grows in the US, parents and adults are increasingly seeking treatment options, driving market demand. Furthermore, the development of tailored treatmentssuch as behavior modification therapies for children and advanced dental appliances for adultshighlights the importance of understanding patient demographics.
The US Dental and Health associations have underscored the significance of addressing these demographic needs to ensure effective management and prevention of complications related to bruxism, thus propelling the growth of the US Sleeping Bruxism Treatment Market.
The US Sleeping Bruxism Treatment Market primarily serves the End User segment comprising Hospitals and Clinics as well as Dental Clinics. Hospitals and Clinics play a crucial role in diagnosing and managing sleeping bruxism, often offering integrated care that includes various specialists who understand both dental and sleep disorders. Dental Clinics are particularly significant as they are typically the first point of contact for patients experiencing teeth grinding and related oral health issues.
These establishments provide tailored treatment options, including custom mouthguards, ensuring effective management of the condition.The rising prevalence of sleep-related disorders in the US has driven the need for specialized treatment in these settings, creating increased opportunities for patient education and access to advanced treatment modalities. Growing awareness about sleep health further supports market growth, highlighting the essential contribution of these End User segments in addressing sleeping bruxism.
As the demand for comprehensive treatment strategies continues to expand, hospitals and clinics, along with dental practices, are pivotal in shaping the landscape of the US Sleeping Bruxism Treatment Market.
The US Sleeping Bruxism Treatment Market is witnessing significant growth due to the increasing awareness about dental health and the associated disorders stemming from bruxism. As individuals become more cognizant of the health risks linked to teeth grinding, demand for effective treatment options is on the rise. This market largely comprises dental devices, medications, and behavioral therapies, with various stakeholders actively participating to address the needs of those suffering from bruxism.
Many companies are focusing on innovative solutions to cater to the growing patient population and improve treatment outcomes. Competitive insights reveal that the market is characterized by a mix of established players and new entrants, each striving to enhance their product portfolios and expand their market presence through strategic collaborations and technological advancements.
In the context of the US Sleeping Bruxism Treatment Market, Sleep Number Corporation has carved out a strong niche by promoting specialized sleep products designed to improve overall sleep quality, which is paramount for individuals suffering from bruxism. The company's strengths lie in its ability to integrate advanced technology into sleep solutions, including adjustable mattresses and sleep tracking systems that help users identify sleep issues that can exacerbate grinding behavior.
With a robust distribution network across the United States, Sleep Number Corporation effectively reaches its target audience by offering customized solutions that appeal to consumers seeking relief from sleep disturbances linked to bruxism. Their commitment to innovation and quality enhances their competitive edge in this specialized market.GlaxoSmithKline, a key player in the US Sleeping Bruxism Treatment Market, has established a substantial presence through its line of oral health products that target the symptoms associated with bruxism.
The company develops and markets a range of medications aimed at alleviating the discomfort caused by teeth grinding, focusing on pharmacological solutions as well as behavioral therapies. GlaxoSmithKline's strengths include a well-established research and development pipeline and strategic mergers and acquisitions that have strengthened its portfolio and market position within the US. The company aims to leverage its extensive sales and distribution networks to reach healthcare providers and consumers effectively. By continually enhancing its offerings and incorporating user feedback into product development, GlaxoSmithKline maintains a competitive edge while adapting to the evolving landscape of the bruxism treatment market in the United States.
Recent developments in the US Sleeping Bruxism Treatment Market have shown a significant focus on enhancing treatment options and the growing awareness of the condition. Sleep Number Corporation, known for its innovative sleep products, is exploring ways to integrate technology into bruxism management. GlaxoSmithKline and Eli Lilly and Company continue to invest in Research and Development for pharmacological treatments.
CPAP.com has reported increased sales of various oral appliances aimed at treating bruxism, reflecting the growing demand for effective solutions. Notably, Procter and Gamble's collaborations with dental care professionals emphasize the importance of preventive measures. Moreover, in March 2023, ResMed announced a strategic partnership with Johnson and Johnson to co-develop a new line of sleep disorder treatments, including those targeting bruxism.
Haleon and OralB have also been active in exploring consumer education campaigns to raise awareness. In the past two years, the US market has experienced a measurable increase in revenues, with growth projected due to rising awareness and improved treatment options. These changes reflect an evolving landscape aimed at addressing the needs of patients suffering from this common sleep-related condition.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 128.77(USD Million) |
| MARKET SIZE 2024 | 138.65(USD Million) |
| MARKET SIZE 2035 | 257.62(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.794% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Sleep Number Corporation, GlaxoSmithKline, CPAP.com, Procter and Gamble, Eli Lilly and Company, HUM Nutrition, OralB, MediNiche, One Dental, Pfizer, Haleon, ResMed, Johnson and Johnson, Scripps Health, Dental Lifeline Network |
| SEGMENTS COVERED | Type, Treatment, Cause, Patient Type, End User |
| KEY MARKET OPPORTUNITIES | Growing awareness of dental health, Increasing demand for oral appliances, Rising stress levels among adults, Advancements in sleep disorder technology, Expanding telemedicine for treatment access |
| KEY MARKET DYNAMICS | increasing prevalence of bruxism, rising awareness of treatment options, advancements in dental technologies, growing demand for custom mouthguards, increasing stress and anxiety levels |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Sleeping Bruxism Treatment Market is expected to be valued at 138.65 million USD in 2024.
By 2035, the market is projected to reach a value of 257.62 million USD.
The market is expected to grow at a CAGR of 5.794% from 2025 to 2035.
In 2024, Primary Bruxism is valued at 83.36 million USD, while Secondary Bruxism is valued at 55.29 million USD.
The Primary Bruxism segment is expected to be valued at 156.52 million USD in 2035.
By 2035, the Secondary Bruxism segment is anticipated to reach a value of 101.1 million USD.
Major players in the market include Sleep Number Corporation, GlaxoSmithKline, Procter and Gamble, and Pfizer, among others.
Emerging trends include increased awareness of dental health, technological advancements in treatment options, and rising demand for personalized care.
Challenges include lack of awareness, varying treatment effectiveness, and competition among numerous healthcare providers.
The global scenario is influencing supply chains and treatment availability, but the demand for effective bruxism treatments remains strong.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
